76 research outputs found
Recommended from our members
Gregory Butler. Bach's Clavier-Ubung III: The Making of a Print. With a Companion Study of the Canonic Variations on "Vom Himmel Hoch," BWV 769.
This article discusses Gregory Butler's Bach's Clavier-Ubung III' The Making of a Print and the authors thoughts on Bach. At the conclusion of a round table on post-World War II developments in Bach research, a long session in which the manuscript studies of Alfred Durr, Georg von Dadelsen, and Robert Marshall were discussed in some detail, Mendel quipped, with a wry smile: "And if the original manuscripts have revealed a lot about Bach's working habits, wait until we take a closer look at the original prints!" The remark drew laughter, as Mendel intended, and struck one at the time as facetious, for how could the prints of Bach's works ever show as much about chronology and the compositional process as the manuscripts? The surviving manuscript materials, written by Bach and his copyists, display a wealth of information that can be unraveled through source-critical investigation: revisions, corrections, organizational second thoughts. The prints, by contrast, appear inscrutable. Uniform and definitive in appearance, made by engravers rather than Bach or his assistants, they seem to be closed books, telling little-if any thing about the genesis of the texts they contain
Roughness of Interfacial Crack Front: Correlated Percolation in the Damage Zone
We show that the roughness exponent zeta of an in-plane crack front slowly
propagating along a heterogeneous interface embeded in a elastic body, is in
full agreement with a correlated percolation problem in a linear gradient. We
obtain zeta=nu/(1+nu) where nu is the correlation length critical exponent. We
develop an elastic brittle model based on both the 3D Green function in an
elastic half-space and a discrete interface of brittle fibers and find
numerically that nu=1.5, We conjecture it to be 3/2. This yields zeta=3/5. We
also obtain by direct numerical simulations zeta=0.6 in excellent agreement
with our prediction. This modelling is for the first time in close agreement
with experimental observations.Comment: 4 pages RevTeX
Spitzer 24 micron Survey of Debris Disks in the Pleiades
We performed a 24 micron 2 Deg X 1 Deg survey of the Pleiades cluster, using
the MIPS instrument on Spitzer. Fifty four members ranging in spectral type
from B8 to K6 show 24 micron fluxes consistent with bare photospheres. All Be
stars show excesses attributed to free-free emission in their gaseous
envelopes. Five early-type stars and four solar-type stars show excesses
indicative of debris disks. We find a debris disk fraction of 25 % for B-A
members and 10 % for F-K3 ones. These fractions appear intermediate between
those for younger clusters and for the older field stars. They indicate a decay
with age of the frequency of the dust-production events inside the planetary
zone, with similar time scales for solar-mass stars as have been found
previously for A-stars.Comment: accepted to Ap
Near and Mid-IR Photometry of the Pleiades, and a New List of Substellar Candidate Members
We make use of new near and mid-IR photometry of the Pleiades cluster in
order to help identify proposed cluster members. We also use the new photometry
with previously published photometry to define the single-star main sequence
locus at the age of the Pleiades in a variety of color-magnitude planes.
The new near and mid-IR photometry extend effectively two magnitudes deeper
than the 2MASS All-Sky Point Source catalog, and hence allow us to select a new
set of candidate very low mass and sub-stellar mass members of the Pleiades in
the central square degree of the cluster. We identify 42 new candidate members
fainter than Ks =14 (corresponding to 0.1 Mo). These candidate members should
eventually allow a better estimate of the cluster mass function to be made down
to of order 0.04 solar masses.
We also use new IRAC data, in particular the images obtained at 8 um, in
order to comment briefly on interstellar dust in and near the Pleiades. We
confirm, as expected, that -- with one exception -- a sample of low mass stars
recently identified as having 24 um excesses due to debris disks do not have
significant excesses at IRAC wavelengths. However, evidence is also presented
that several of the Pleiades high mass stars are found to be impacting with
local condensations of the molecular cloud that is passing through the Pleiades
at the current epoch.Comment: Accepted to ApJS; data tables and embedded-figure version available
at http://spider.ipac.caltech.edu/staff/stauffer/pleiades07
Tipping Points in 1-dimensional Schelling Models with Switching Agents
Schellingâs spacial proximity model was an early agent-based model, illustrating how ethnic segregation can emerge, unwanted, from the actions of citizens acting according to individual local preferences. Here a 1-dimensional unperturbed variant is studied under switching agent dynamics, interpretable as being open in that agents may enter and exit the model. Following the authorsâ work (Barmpalias et al., FOCS, 2014) and that of Brandt et al. (Proceedings of the 44th ACM Symposium on Theory of Computing (STOC 2012), 2012), rigorous asymptotic results are established. The dynamic allows either type to take over almost everywhere. Tipping points are identified between the regions of takeover and staticity. In a generalization of the models considered in [1] and [3], the modelâs parameters comprise the initial proportions of the two types, along with independent values of the tolerance for each type. This model comprises a 1-dimensional spin-1 model with spin dependent external field, as well as providing an example of cascading behaviour within a network
Ozonesonde Quality Assurance: JOSIE-SHADOZ (2017) and SHALLOTS (2018)
Ozonesonde data constitute a mainstay of satellite calibration and are used for climatologies and analysis of trends, especially in the lower stratosphere where satellites are most uncertain. The electrochemical-concentration cell (ECC) ozonesonde has been deployed at ~100 stations worldwide since the 1960s, with changes over time in manufacture and procedures, including details of the cell chemical solution and data processing. As a consequence, there are biases among different stations and discontinuities in profile timeseries from individual site records. Since 1996 the Jlich [Germany] Ozone Sonde Intercomparison Experiment (JOSIE) has periodically tested ozonesondes in a simulation chamber designated the World Calibration Centre for Ozonesondes by WMO. In October- November 2017 a JOSIE campaign evaluated the sondes and procedures used in SHADOZ (Southern Hemisphere Additional Ozonesondes), a 14-station tropical and subtropical network. A distinctive feature of the 2017 JOSIE was that the tests were conducted by operators from eight SHADOZ stations; Nairobi, Natal, Irene, Costa Rica, Paramaribo, Reunion, Hanoi, Kuala Lumpur. Experimental protocols and preliminary results for the SHADOZ sonde configurations, which represent most of those in use today, are described. SHADOZ stations that follow WMO-recommended protocols record total ozone within 3% of the JOSIE reference instrument. Instrument biases noted in prior JOSIE and field tests like BESOS (2004) were noted in JOSIE-2017, with maximum effect in the stratosphere. In June 2018 we organized a series of dual launches during the OWLETS II campaign in the Maryland and Chesapeake Bay area (SHALLOTS = SHADOZ-OWLETS ParaLLel Ozonesonde Test Study). Instrument and solution types were varied as in JOSIE-2017 and three radiosonde-ozonesonde variants were tested. An example of a parallel sampling in SHALLOTS, from a Greenbelt EnSCI-iMet sonde combination flown with the Wallops SPCLMS package, is illustrated in the Figure. The result was a range of biases but in general the instrument combination (EnSCI-iMet) deployed at 11 SHADOZ stations recorded ~5-10% less ozone in the stratosphere than the SPC ECC sonde flown with a Vaisala or LMS system. These 2017 and 2018 results and prior JOSIEs demonstrate that regular testing is essential to maintain best practices in ozonesonde operations and to ensure high-quality data for the ozone assessment communities
Defining the critical hurdles in cancer immunotherapy
Scientific discoveries that provide strong evidence of antitumor effects in preclinical models often encounter significant delays before being tested in patients with cancer. While some of these delays have a scientific basis, others do not. We need to do better. Innovative strategies need to move into early stage clinical trials as quickly as it is safe, and if successful, these therapies should efficiently obtain regulatory approval and widespread clinical application. In late 2009 and 2010 the Society for Immunotherapy of Cancer (SITC), convened an "Immunotherapy Summit" with representatives from immunotherapy organizations representing Europe, Japan, China and North America to discuss collaborations to improve development and delivery of cancer immunotherapy. One of the concepts raised by SITC and defined as critical by all parties was the need to identify hurdles that impede effective translation of cancer immunotherapy. With consensus on these hurdles, international working groups could be developed to make recommendations vetted by the participating organizations. These recommendations could then be considered by regulatory bodies, governmental and private funding agencies, pharmaceutical companies and academic institutions to facilitate changes necessary to accelerate clinical translation of novel immune-based cancer therapies. The critical hurdles identified by representatives of the collaborating organizations, now organized as the World Immunotherapy Council, are presented and discussed in this report. Some of the identified hurdles impede all investigators; others hinder investigators only in certain regions or institutions or are more relevant to specific types of immunotherapy or first-in-humans studies. Each of these hurdles can significantly delay clinical translation of promising advances in immunotherapy yet if overcome, have the potential to improve outcomes of patients with cancer
- âŠ